
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5496391
[patent_doc_number] => 20090264419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/433925
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42693
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433925
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433925 | CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION | Apr 30, 2009 | Abandoned |
Array
(
[id] => 8270388
[patent_doc_number] => 08211891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/433191
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16202
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12433191
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433191 | Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors | Apr 29, 2009 | Issued |
Array
(
[id] => 6637953
[patent_doc_number] => 20100035946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'INDOLINE ANTI-CANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/432615
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28663
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035946.pdf
[firstpage_image] =>[orig_patent_app_number] => 12432615
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/432615 | Indoline anti-cancer agents | Apr 28, 2009 | Issued |
Array
(
[id] => 10844580
[patent_doc_number] => 08871753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Macrocyclic compounds and their use as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/429014
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 265659
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12429014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429014 | Macrocyclic compounds and their use as kinase inhibitors | Apr 22, 2009 | Issued |
Array
(
[id] => 5954811
[patent_doc_number] => 20110034687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'PROCESS FOR PRODUCING AMIDE OR LACTAM'
[patent_app_type] => utility
[patent_app_number] => 12/988758
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2685
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034687.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988758 | Process for producing amide or lactam | Apr 21, 2009 | Issued |
Array
(
[id] => 6189949
[patent_doc_number] => 20110172233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'SONIC HEDGEHOG MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/988755
[patent_app_country] => US
[patent_app_date] => 2009-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 35344
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988755
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988755 | Sonic hedgehog modulators | Apr 20, 2009 | Issued |
Array
(
[id] => 5986727
[patent_doc_number] => 20110098241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'RAPAMYCIN ANALOGS AS ANTI-CANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/936500
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16063
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098241.pdf
[firstpage_image] =>[orig_patent_app_number] => 12936500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936500 | RAPAMYCIN ANALOGS AS ANTI-CANCER AGENTS | Apr 12, 2009 | Abandoned |
Array
(
[id] => 8807821
[patent_doc_number] => 08445473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/937114
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34100
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937114
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937114 | Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof | Apr 12, 2009 | Issued |
Array
(
[id] => 53277
[patent_doc_number] => 07772224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'CGRP receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/417911
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37090
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772224.pdf
[firstpage_image] =>[orig_patent_app_number] => 12417911
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/417911 | CGRP receptor antagonists | Apr 2, 2009 | Issued |
Array
(
[id] => 7527451
[patent_doc_number] => 08044043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'CGRP receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/415624
[patent_app_country] => US
[patent_app_date] => 2009-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32326
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12415624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/415624 | CGRP receptor antagonists | Mar 30, 2009 | Issued |
Array
(
[id] => 8797136
[patent_doc_number] => 08436005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Macrocyclic pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/413168
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12413168
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/413168 | Macrocyclic pyrimidine derivatives | Mar 26, 2009 | Issued |
Array
(
[id] => 9166730
[patent_doc_number] => 08592407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Pyrrolo[2,1-c][1,4] benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 13/129935
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8117
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129935
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129935 | Pyrrolo[2,1-c][1,4] benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof | Mar 23, 2009 | Issued |
Array
(
[id] => 8283064
[patent_doc_number] => 08217167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Phenanthrylphenol linked pyrrolo [2, l-c] [l, 4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/922123
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3970
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922123
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922123 | Phenanthrylphenol linked pyrrolo [2, l-c] [l, 4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof | Mar 11, 2009 | Issued |
Array
(
[id] => 9389355
[patent_doc_number] => 08685953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Linear and cyclic guanidine derivatives, method of preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/922232
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2881
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922232 | Linear and cyclic guanidine derivatives, method of preparation and uses thereof | Mar 11, 2009 | Issued |
Array
(
[id] => 142116
[patent_doc_number] => 07691846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Lactam-containing compounds and derivatives thereof as factor Xa inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/401401
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80480
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691846.pdf
[firstpage_image] =>[orig_patent_app_number] => 12401401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/401401 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | Mar 9, 2009 | Issued |
Array
(
[id] => 7988359
[patent_doc_number] => 08076475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Process'
[patent_app_type] => utility
[patent_app_number] => 12/921199
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4137
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076475.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921199
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921199 | Process | Mar 5, 2009 | Issued |
Array
(
[id] => 5474335
[patent_doc_number] => 20090247501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/396919
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5594
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247501.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396919
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396919 | PROTEIN KINASE INHIBITORS | Mar 2, 2009 | Abandoned |
Array
(
[id] => 6594892
[patent_doc_number] => 20100048536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Novel Substituted Diaryl Azepine Derivatives as Integrin Ligands'
[patent_app_type] => utility
[patent_app_number] => 12/396698
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37358
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396698
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396698 | Novel Substituted Diaryl Azepine Derivatives as Integrin Ligands | Mar 2, 2009 | Abandoned |
Array
(
[id] => 8802379
[patent_doc_number] => 08440653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => '3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/919973
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29190
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919973 | 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists | Feb 26, 2009 | Issued |
Array
(
[id] => 8141335
[patent_doc_number] => 20120095213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'CINNAMIDO-PYRROLO[2,1-C][1,4]BENZODIAZEPINES AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/128112
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6849
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095213.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128112 | Cinnamido-pyrrolo[2,1-C][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof | Feb 26, 2009 | Issued |